See this report from science based pharmacy.
On 14 April 2014, I submitted a formal complaint about the promotion of the same product (called Jet-ease in Australia) to the Therapeutic Goods Advertising Complaint Resolution Panel (TGACRP).
I alleged that the information provided on Jet-ease web site breached a number of sections of the Therapeutic Goods Advertising Code, especially the statement that it had, “been proven effective in a clinical trial”.
I also noted that this product was promoted and sold in a large number of airport pharmacies, health stores and other outlets: http://www.jetease.com.au/auretail.html.
On June 2, 2014 I was informed the complaint had been sent to the Therapeutic Goods Administration “because of the possible breach of section 42DL(1)(g) of the Act (the product may not be on the Australian Register of Therapeutic Goods)”.
On June 19, 2014 the TGA acknowledged receipt of this (and other complaints about homeopathic products) but subsequently I have heard no more.
Meanwhile, promotion in Australia continues unchanged.
It would seem that the N.Z. regulatory system is much more efficient than the Australian one!by